Zobrazeno 1 - 10
of 270
pro vyhledávání: '"Gheath, Alatrash"'
Autor:
Patrick K. Reville, Hagop M. Kantarjian, Farhad Ravandi, Elias Jabbour, Courtney D. DiNardo, Naval Daver, Naveen Pemmaraju, Maro Ohanian, Yesid Alvarado, Lianchun Xiao, Gheath Alatrash, Sanam Loghavi, Caitlin R. Rausch, Gautam Borthakur, Marina Konopleva, Jorge Cortes, Tapan M. Kadia
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 3, Pp 1-5 (2021)
Externí odkaz:
https://doaj.org/article/8f2495e6bad446078d3349076adbe94b
Autor:
Oren Pasvolsky, May Daher, Gheath Alatrash, David Marin, Naval Daver, Farhad Ravandi, Katy Rezvani, Elizabeth Shpall, Partow Kebriaei
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
Despite advances in the understanding of the genetic landscape of acute myeloid leukemia (AML) and the addition of targeted biological and epigenetic therapies to the available armamentarium, achieving long-term disease-free survival remains an unmet
Externí odkaz:
https://doaj.org/article/531a8129db1c4c4ea4622b49a3462c71
Autor:
Anne E. O'Shea, Guy T. Clifton, Na Qiao, Brandy M. Heckman-Stoddard, Malgorzata Wojtowicz, Eileen Dimond, Isabelle Bedrosian, Diane Weber, Judy E. Garber, Alexander Husband, Ricardo Pastorello, J. Jack Lee, Mike Hernandez, Diane D. Liu, Lana A. Vornik, Powel H. Brown, Gheath Alatrash, George E. Peoples, Elizabeth A. Mittendorf
Publikováno v:
Cancer Prevention Research. :OF1-OF9
NeuVax is a vaccine comprised of the HER2-derived MHC class I peptide E75 (nelipepimut-S, NPS) combined with GM-CSF. We completed a randomized trial of preoperative vaccination with NeuVax versus GM-CSF alone in patients with ductal carcinoma in situ
Autor:
Ankur Tiwari, Guy Clifton, Carmen Calfa, Gheath Alatrash, Jarrod Holmes, Isabelle Bedrosian, George Peoples, Elizabeth A. Mittendorf
Publikováno v:
Cancer Research. 83:P4-07
INTRODUCTION: The HER2-targeted peptide vaccine nelipepimut-S + GM-CSF (NeuVax) has been shown to be safe, immunogenic, and potentially synergistic with trastuzumab. Here we present the results of a randomized phase 2 trial assessing the ability of n
Autor:
Curtis Marcoux, David Marin, Jeremy Ramdial, Gheath AlAtrash, Amin M. Alousi, Betul Oran, Partow Kebriaei, Uday R. Popat, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Rohtesh S. Mehta
Publikováno v:
American Journal of Hematology. 98:712-719
Autor:
Abhishek Maiti, Courtney D. DiNardo, Maro Ohanian, Naveen Pemmaraju, Naval Daver, Gautam Borthakur, Farhad Ravandi, Ghayas C. Issa, Guillermo Garcia-Manero, Nitin Jain, Tapan M. Kadia, Lucia Masarova, William G. Wierda, Musa Yilmaz, Yesid Alvarado, Elias Jabbour, Nicholas Short, Koichi Takahashi, Sanam Loghavi, Keyur P. Patel, Kathryn Montalbano, Sherry A. Pierce, Carol A. Bivins, Rohtesh S. Mehta, Gheath Alatrash, Uday R Popat, Partow Kebriaei, Betul Oran, Elizabeth J Shpall, Richard E Champlin, Hagop Kantarjian, Marina Konopleva
Publikováno v:
Blood. 140:7725-7728
Autor:
Jefferson L. Lansford, Udara Dharmasiri, Shengjie Chai, Sally A. Hunsucker, Dante S. Bortone, James E. Keating, Ian M. Schlup, Gary L. Glish, Edward J. Collins, Gheath Alatrash, Jeffrey J. Molldrem, Paul M. Armistead, Benjamin G. Vincent
Publikováno v:
Blood Advances, Vol 2, Iss 16, Pp 2052-2062 (2018)
Abstract: T-cell responses to minor histocompatibility antigens (mHAs) mediate both antitumor immunity (graft-versus-leukemia [GVL]) and graft-versus-host disease (GVHD) in allogeneic stem cell transplant. Identifying mHAs with high allele frequency,
Externí odkaz:
https://doaj.org/article/911fb5a592c14d889c5fbd24ef820db9
Autor:
Elizabeth A. Mittendorf, George E. Peoples, Gheath Alatrash, Powel H. Brown, Lana A. Vornik, Diane D. Liu, Mike Hernandez, J. Jack Lee, Ricardo Pastorello, Alexander Husband, Judy E. Garber, Diane Weber, Isabelle Bedrosian, Eileen Dimond, Malgorzata Wojtowicz, Brandy M. Heckman-Stoddard, Na Qiao, Guy T. Clifton, Anne E. O'Shea
NeuVax is a vaccine comprised of the HER2-derived MHC class I peptide E75 (nelipepimut-S, NPS) combined with GM-CSF. We completed a randomized trial of preoperative vaccination with NeuVax versus GM-CSF alone in patients with ductal carcinoma in situ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f651670fa931553a9dd3bc374ba8183
https://doi.org/10.1158/1940-6207.c.6642622.v1
https://doi.org/10.1158/1940-6207.c.6642622.v1
Autor:
Elizabeth A. Mittendorf, George E. Peoples, Gheath Alatrash, Powel H. Brown, Lana A. Vornik, Diane D. Liu, Mike Hernandez, J. Jack Lee, Ricardo Pastorello, Alexander Husband, Judy E. Garber, Diane Weber, Isabelle Bedrosian, Eileen Dimond, Malgorzata Wojtowicz, Brandy M. Heckman-Stoddard, Na Qiao, Guy T. Clifton, Anne E. O'Shea
Supplementary Table S5: HER2 expression in biopsy and resection specimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1943aef419ca844e93810d26a9c95bd6
https://doi.org/10.1158/1940-6207.22806877.v1
https://doi.org/10.1158/1940-6207.22806877.v1
Autor:
Elizabeth A. Mittendorf, George E. Peoples, Gheath Alatrash, Powel H. Brown, Lana A. Vornik, Diane D. Liu, Mike Hernandez, J. Jack Lee, Ricardo Pastorello, Alexander Husband, Judy E. Garber, Diane Weber, Isabelle Bedrosian, Eileen Dimond, Malgorzata Wojtowicz, Brandy M. Heckman-Stoddard, Na Qiao, Guy T. Clifton, Anne E. O'Shea
Supplementary Fig. S1: Nelipepimut-S (NPS)-specific cytotoxic T lymphocyte (CTL) responses in patients receiving NeuVax with corresponding HER2 changes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e59b72fc42e69fd9132efc0311f9f74
https://doi.org/10.1158/1940-6207.22806895.v1
https://doi.org/10.1158/1940-6207.22806895.v1